Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The Stock for 1999(Polymedica)PLMD(Medical Supply Co.) -- Ignore unavailable to you. Want to Upgrade?

To: Sam who wrote (1531)	7/27/1998 7:11:00 PM
From: Dennis C	Respond to of 3414

Diabetes related news: Group Urges Ban of Diabetes Drug WASHINGTON (AP) - Consumer advocates today urged the government to ban Rezulin, a widely used diabetes drug which could be connected with at least 26 worldwide deaths from liver failure. The call, issued by the consumer group Public Citizen, comes seven months after the drug was recalled in Britain because of its liver risks. The Food and Drug Administration last week upgraded its warning for Rezulin, instructing doctors to test patients' livers for signs of toxicity during the first eight months of using the drug, but Public Citizen insisted that warnings aren't enough.